On the initiative of Union Minister Nitin Gadkari, Genetek Lifesciences of Wardha has received FDA approval to make Amphotericin B injection for black fungus infection during the COVID-19 period, a statement issued by the minister’s office said. Its production will begin in the next 15 days at its Wardha plant. Right now the cost of an injection is Rs 7,000 and people are not getting it easily. The injection made in Wardha will be available for just Rs 1,200, it added.
A total of 20,000 injections per day will be manufactured in the plant. Genetek Lifesciences started production of Remdesivir injections, used in the treatment of COVID-19, in Wardha from Wednesday. The company has received a loan licence to manufacture Remdesivir.
In the amicus brief, Google said: “The regulation at issue here the H-4 Rule, US Department of Homeland Security, Employment Authorization for Certain H-4 Dependent Spouses, 80 Fed. Reg. 10,284 (Feb. 25, 2015) provides work authorization to more than 90,000 H-4 visa holders (spouses of certain H-1B visa holders), more than 90 per cent of whom are women.
“Invalidation of this rule would result in these talented individuals being barred from the workplace, forcibly severing tens of thousands of employment relationships across the country,” it said.
The results would be utterly destructive for the families impacted; by just one measure, about 87 per cent of these families have made crucial life decisions on the promise of H-4 employment, including whether to have a child and whether to buy a house, it said.